Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records

ABSTRACT Purpose A semi‐automated high‐dimensional propensity score (hd‐PS) algorithm has been proposed to adjust for confounding in claims databases. The feasibility of using this algorithm in other types of healthcare databases is unknown. Methods We estimated the comparative safety of traditional...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacoepidemiology and drug safety 2011-08, Vol.20 (8), p.849-857
Hauptverfasser: Toh, Sengwee, García Rodríguez, Luis A., Hernán, Miguel A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Purpose A semi‐automated high‐dimensional propensity score (hd‐PS) algorithm has been proposed to adjust for confounding in claims databases. The feasibility of using this algorithm in other types of healthcare databases is unknown. Methods We estimated the comparative safety of traditional non‐steroidal anti‐inflammatory drugs (NSAIDs) and selective COX‐2 inhibitors regarding the risk of upper gastrointestinal bleeding (UGIB) in The Health Improvement Network, an electronic medical record (EMR) database in the UK. We compared the adjusted effect estimates when the confounders were identified using expert knowledge or the semi‐automated hd‐PS algorithm. Results Compared with the 411,616 traditional NSAID initiators, the crude odds ratio (OR) of UGIB was 1.50 (95%CI: 0.98, 2.28) for the 43,569 selective COX‐2 inhibitor initiators. The OR dropped to 0.81 (0.52, 1.27) upon adjustment for known risk factors for UGIB that are typically available in both claims and EMR databases. The OR remained similar when further adjusting for covariates—smoking, alcohol consumption, and body mass index—that are not typically recorded in claims databases (OR 0.81; 0.51, 1.26) or adding 500 empirically identified covariates using the hd‐PS algorithm (OR 0.78; 0.49, 1.22). Adjusting for age and sex plus 500 empirically identified covariates produced an OR of 0.87 (0.56, 1.34). Conclusions The hd‐PS algorithm can be implemented in pharmacoepidemiologic studies that use primary care EMR databases such as The Health Improvement Network. For the NSAID–UGIB association for which major confounders are well known, further adjustment for covariates selected by the algorithm had little impact on the effect estimate. Copyright © 2011 John Wiley & Sons, Ltd.
ISSN:1053-8569
1099-1557
DOI:10.1002/pds.2152